Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1990-2-22
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0883-2897
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
633-6
|
| pubmed:dateRevised |
2008-2-21
|
| pubmed:meshHeading | |
| pubmed:year |
1989
|
| pubmed:articleTitle |
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches.
|
| pubmed:affiliation |
Istituto Nazionale Tumori, Milano, Italy.
|
| pubmed:publicationType |
Journal Article
|